Schwab Network 对 $MRNA 的判断变化

频道资料 →频道引用的来源:BFA and JP Morgan、Baird、Bank of America、Barclays、Berenberg、Bernstein、Bernstein, with a Jefferies target cut noted、Bilal Little、Bird (analyst firm)、CEO、CEO Joe Dominguez、Caner、Citi、Citigroup、Citizens、Daiwa、Dan Deming and Michael Monahan、Dan Ies; Morgan Stanley、Dan Ives、Dan Ives and unnamed analysts、Deutsche Bank、Erit Research、Evercore ISI、Evercore ISI; Dan Ives、Goldman Sachs、JP Morgan Chase、JPMorgan、JPMorgan Chase、James Demerard of Wall Street Research、Jefferies、Jefferies, UBS and Citigroup、Jensen Huang; Dan Ives、KeyBank、Loop Capital、Mattie Natsson、Michael Saylor、Milius (analyst)、Morgan Stanley、Northrop、Oppenheimer、Oppenheimer, Freedom Broker、Oracle、PFA analysts、Quantum CEO、RBC、Reddit CEO、Rothschild Redburn、SK Hynix、Seth、Tim Bigham、Tim and KG、Truist、UBS、Wall Street Journal、Wedbush、Wells Fargo、analysts、the street共 4 条

Schwab Network 自 2026-09-30 起在 4 个视频里谈过 $MRNA。

2026-11-05
《The Big 3: HCA, ISRG, MRNA》
AI 摘要 · 说话者看好MRNA,理由是III期数据显示一款与Keytruda合作的药物使皮肤癌相关死亡减少约42%,且自今年年初以来呈上升趋势,但并非长期上升趋势。不过该股在255附近旧高点受阻,RSI在上升与下降趋势线之间方向未明;需突破任一侧才能明确看涨或看跌方向,若跌破238.25的5日EMA可能打开219。

你这里的下一个名字也属于医疗保健板块,但它是一家制药公司,跌幅比一些其他公司稍大,Moderna下跌了4.3%,今年迄今为止它经常登上头条。

Your last name here is also in the healthcare sector, but it's a pharmaceutical company that has fallen a little more than some of the others, down 4.3% for Moderna, which has been making headlines a lot so far this year.

Moderna的大局:大家都通过其新冠疫苗认识他们,但他们也在做一些很酷的事情,比如与Keytruda的合作,以及他们提供的一种已进入第三阶段的药物,目前显示它可以将皮肤癌相关死亡减少约42%。

所以,这是好消息。因此,我在长期趋势中看好Moderna,我不该说长期上升趋势。自今年年初以来,它一直处于上升趋势。

Well, the big picture for Moderna: everyone knows them from their COVID vaccine, but they also have some cool things they're working on, like the partnership with Keytruda and the drug they've provided that's reached Phase 3, which currently shows it can reduce skin cancer-related deaths by about 42%.

So, this is good news. So, I like Moderna in a long-term trend, I shouldn't say a long-term upward trend. It has been on an upward trend since the beginning of this year.

2026-10-23
《Friday's First Moves: MRNA Cancer Vaccine Trial Leaks, DECK Earnings, NCLH Downgrade》引用来源:analysts
AI 摘要 · MRNA 下跌5.5%,起因是后期癌症疫苗阳性数据泄露(相较单用 Keytruda,复发/死亡风险相对降低42%)——这并非糟糕的结果。分析师认为这是“买传闻、卖新闻”:该股一年内上涨600%,已提前计入突破性进展,因此此次下跌看起来像是在官方三期结果公布前的获利了结。

Diane King Hall和我一起来看Moderna。我们昨天稍微谈过这个。昨天出现了一轮剧烈而戏剧性的抛售。

Diane King Hall is joining me to take a look at Moderna . We talked a little about this yesterday. It was an intense and dramatic sell-off yesterday.

昨天,这导致市值减少了240亿美元。Moderna今天仍面临压力。但这并不意味着业绩很差。这些压力出现在有关癌症疫苗试验的一些信息被泄露之后。我们原本预计它会在本周末发布。它仍计划在本周末发布。

Yesterday, this resulted in a $24 billion reduction in market value. There is ongoing pressure on Moderna today. But that doesn't mean the results were bad. These pressures come after some information regarding cancer vaccine trials was leaked .

We were expecting it to be released at the end of this week. It is still scheduled to be released at the end of this week.

2026-10-23
WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak
订阅或试用后可见这一步的正文
2026-09-30看跌
Wednesday's First Moves: MRNA Downgrade, BA Jet Contract, JBL Earnings
订阅或试用后可见这一步的正文
更早的 2 条正文需要订阅
最近 2 条的正文公开可读。更早的条目保留日期与方向,正文随订阅解锁。
订阅后阅读全部 2 条更早的观点